| Typicality: | 0.580 |
| Saliency: | 0.535 |
| for treatment | 7 | purpose |
| in 167 centres | 4 | location |
| between 1992 | 2 | temporal |
| trial → be conducted in → europe | 64 |
| trial → be conducted across → europe | 6 |
| trial → be conducted in → the eu | 4 |
| trial → be performed in → europe | 4 |
| trial → be conducted in → western europe | 3 |
| trial → be conducted by → the european organisation | 3 |
| negative | neutral | positive |
| 0.092 | 0.820 | 0.089 |
| Raw frequency | 84 |
| Normalized frequency | 0.535 |
| Modifier score | 0.814 |
| Perplexity | 70.458 |